APO Research
Talk to an analyst

APO RESEARCH · REPORT

Seasonal Influenza Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Seasonal Influenza Vaccines Market Analysis and Forecast 2026-2032

19 December 2025200 pages

Choose your research edition.

Industry ResearchSeasonal Influenza Vaccines Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Seasonal Influenza Vaccines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Seasonal Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Seasonal Influenza Vaccines Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Seasonal Influenza Vaccines Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Seasonal Influenza Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Seasonal Influenza Vaccines include Changsheng Bio-Technology, Sanofi, Novartis International AG, Merck & Co., Inc., Pfizer Inc, GlaxoSmithKline plc, AstraZeneca, Viatris Inc. and Vaxess Technologies Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Seasonal Influenza Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Seasonal Influenza Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Seasonal Influenza Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Seasonal Influenza Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Seasonal Influenza Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Seasonal Influenza Vaccines sales, projected growth trends, production technology, application and end-user industry.

Seasonal Influenza Vaccines Segment by Company

Changsheng Bio-Technology

Sanofi

Novartis International AG

Merck & Co., Inc.

Pfizer Inc

GlaxoSmithKline plc

AstraZeneca

Viatris Inc.

Vaxess Technologies Inc

Sinovac Biotech Ltd

SINOVAC

OSIVAX

Jiangsu Simcere Vaxtec Bio-pharmaceutical

EMERGEX VACCINES

EMERGENT

Dalian Hissen Bio-pharm

CSL Limited

Ccbio SA

Aleph Biomedical

Abbott Laboratories

Seasonal Influenza Vaccines Segment by Type

Type B

Type A (H3N2)

Type A (H1N1)

Seasonal Influenza Vaccines Segment by Application

Adults

Pediatrics

Elderly

Adolescence

Seasonal Influenza Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasonal Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Seasonal Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasonal Influenza Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Seasonal Influenza Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Seasonal Influenza Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Seasonal Influenza Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Seasonal Influenza Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Type B Major Manufacturers Table 3. Type A (H3N2) Major Manufacturers Table 4. Type A (H1N1) Major Manufacturers Table 5. Global Seasonal Influenza Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Adults Major Manufacturers Table 7. Pediatrics Major Manufacturers Table 8. Elderly Major Manufacturers Table 9. Adolescence Major Manufacturers Table 10. Seasonal Influenza Vaccines Industry Trends Table 11. Seasonal Influenza Vaccines Industry Drivers Table 12. Seasonal Influenza Vaccines Industry Opportunities and Challenges Table 13. Seasonal Influenza Vaccines Industry Restraints Table 14. Global Seasonal Influenza Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Seasonal Influenza Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Seasonal Influenza Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2021-2026) Table 18. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2027-2032) Table 19. Global Seasonal Influenza Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 20. Global Seasonal Influenza Vaccines Sales by Region (2021-2026) & (W Units) Table 21. Global Seasonal Influenza Vaccines Sales by Region (2027-2032) & (W Units) Table 22. Global Seasonal Influenza Vaccines Sales Market Share by Region (2021-2026) Table 23. Global Seasonal Influenza Vaccines Sales Market Share by Region (2027-2032) Table 24. Global Seasonal Influenza Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Seasonal Influenza Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Seasonal Influenza Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2021-2026) Table 28. Global Seasonal Influenza Vaccines Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Seasonal Influenza Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Seasonal Influenza Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Seasonal Influenza Vaccines Manufacturers, Product Type & Application Table 32. Global Seasonal Influenza Vaccines Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Seasonal Influenza Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Seasonal Influenza Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Seasonal Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Seasonal Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2021-2026) Table 39. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2027-2032) Table 40. Global Seasonal Influenza Vaccines Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 41. Global Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units) Table 42. Global Seasonal Influenza Vaccines Sales by Type (2027-2032) & (W Units) Table 43. Global Seasonal Influenza Vaccines Sales Market Share by Type (2021-2026) Table 44. Global Seasonal Influenza Vaccines Sales Market Share by Type (2027-2032) Table 45. Global Seasonal Influenza Vaccines Price by Type (2021-2026) & (US$/Unit) Table 46. Global Seasonal Influenza Vaccines Price by Type (2027-2032) & (US$/Unit) Table 47. Global Seasonal Influenza Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Seasonal Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Seasonal Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2021-2026) Table 51. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2027-2032) Table 52. Global Seasonal Influenza Vaccines Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 53. Global Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units) Table 54. Global Seasonal Influenza Vaccines Sales by Application (2027-2032) & (W Units) Table 55. Global Seasonal Influenza Vaccines Sales Market Share by Application (2021-2026) Table 56. Global Seasonal Influenza Vaccines Sales Market Share by Application (2027-2032) Table 57. Global Seasonal Influenza Vaccines Price by Application (2021-2026) & (US$/Unit) Table 58. Global Seasonal Influenza Vaccines Price by Application (2027-2032) & (US$/Unit) Table 59. Changsheng Bio-Technology Company Information Table 60. Changsheng Bio-Technology Business Overview Table 61. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio Table 63. Changsheng Bio-Technology Recent Development Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Sanofi Seasonal Influenza Vaccines Product Portfolio Table 68. Sanofi Recent Development Table 69. Novartis International AG Company Information Table 70. Novartis International AG Business Overview Table 71. Novartis International AG Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Novartis International AG Seasonal Influenza Vaccines Product Portfolio Table 73. Novartis International AG Recent Development Table 74. Merck & Co., Inc. Company Information Table 75. Merck & Co., Inc. Business Overview Table 76. Merck & Co., Inc. Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio Table 78. Merck & Co., Inc. Recent Development Table 79. Pfizer Inc Company Information Table 80. Pfizer Inc Business Overview Table 81. Pfizer Inc Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Pfizer Inc Seasonal Influenza Vaccines Product Portfolio Table 83. Pfizer Inc Recent Development Table 84. GlaxoSmithKline plc Company Information Table 85. GlaxoSmithKline plc Business Overview Table 86. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio Table 88. GlaxoSmithKline plc Recent Development Table 89. AstraZeneca Company Information Table 90. AstraZeneca Business Overview Table 91. AstraZeneca Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. AstraZeneca Seasonal Influenza Vaccines Product Portfolio Table 93. AstraZeneca Recent Development Table 94. Viatris Inc. Company Information Table 95. Viatris Inc. Business Overview Table 96. Viatris Inc. Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Viatris Inc. Seasonal Influenza Vaccines Product Portfolio Table 98. Viatris Inc. Recent Development Table 99. Vaxess Technologies Inc Company Information Table 100. Vaxess Technologies Inc Business Overview Table 101. Vaxess Technologies Inc Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio Table 103. Vaxess Technologies Inc Recent Development Table 104. Sinovac Biotech Ltd Company Information Table 105. Sinovac Biotech Ltd Business Overview Table 106. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio Table 108. Sinovac Biotech Ltd Recent Development Table 109. SINOVAC Company Information Table 110. SINOVAC Business Overview Table 111. SINOVAC Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. SINOVAC Seasonal Influenza Vaccines Product Portfolio Table 113. SINOVAC Recent Development Table 114. OSIVAX Company Information Table 115. OSIVAX Business Overview Table 116. OSIVAX Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. OSIVAX Seasonal Influenza Vaccines Product Portfolio Table 118. OSIVAX Recent Development Table 119. Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information Table 120. Jiangsu Simcere Vaxtec Bio-pharmaceutical Business Overview Table 121. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio Table 123. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Development Table 124. EMERGEX VACCINES Company Information Table 125. EMERGEX VACCINES Business Overview Table 126. EMERGEX VACCINES Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio Table 128. EMERGEX VACCINES Recent Development Table 129. EMERGENT Company Information Table 130. EMERGENT Business Overview Table 131. EMERGENT Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. EMERGENT Seasonal Influenza Vaccines Product Portfolio Table 133. EMERGENT Recent Development Table 134. Dalian Hissen Bio-pharm Company Information Table 135. Dalian Hissen Bio-pharm Business Overview Table 136. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio Table 138. Dalian Hissen Bio-pharm Recent Development Table 139. CSL Limited Company Information Table 140. CSL Limited Business Overview Table 141. CSL Limited Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. CSL Limited Seasonal Influenza Vaccines Product Portfolio Table 143. CSL Limited Recent Development Table 144. Ccbio SA Company Information Table 145. Ccbio SA Business Overview Table 146. Ccbio SA Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Ccbio SA Seasonal Influenza Vaccines Product Portfolio Table 148. Ccbio SA Recent Development Table 149. Aleph Biomedical Company Information Table 150. Aleph Biomedical Business Overview Table 151. Aleph Biomedical Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio Table 153. Aleph Biomedical Recent Development Table 154. Abbott Laboratories Company Information Table 155. Abbott Laboratories Business Overview Table 156. Abbott Laboratories Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio Table 158. Abbott Laboratories Recent Development Table 159. North America Seasonal Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 160. North America Seasonal Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 161. North America Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units) Table 162. North America Seasonal Influenza Vaccines Sales by Type (2027-2032) & (W Units) Table 163. North America Seasonal Influenza Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 164. North America Seasonal Influenza Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 165. North America Seasonal Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 166. North America Seasonal Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 167. North America Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units) Table 168. North America Seasonal Influenza Vaccines Sales by Application (2027-2032) & (W Units) Table 169. North America Seasonal Influenza Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 170. North America Seasonal Influenza Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 171. North America Seasonal Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. North America Seasonal Influenza Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. North America Seasonal Influenza Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. North America Seasonal Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 175. North America Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 176. North America Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units) Table 177. North America Seasonal Influenza Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 178. North America Seasonal Influenza Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 179. United States Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 180. Canada Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 181. Europe Seasonal Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 182. Europe Seasonal Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 183. Europe Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units) Table 184. Europe Seasonal Influenza Vaccines Sales by Type (2027-2032) & (W Units) Table 185. Europe Seasonal Influenza Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 186. Europe Seasonal Influenza Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 187. Europe Seasonal Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 188. Europe Seasonal Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 189. Europe Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units) Table 190. Europe Seasonal Influenza Vaccines Sales by Application (2027-2032) & (W Units) Table 191. Europe Seasonal Influenza Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 192. Europe Seasonal Influenza Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 193. Europe Seasonal Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Europe Seasonal Influenza Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Europe Seasonal Influenza Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Europe Seasonal Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 197. Europe Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 198. Europe Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units) Table 199. Europe Seasonal Influenza Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 200. Europe Seasonal Influenza Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 201. Germany Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 202. France Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 203. U.K. Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 204. Italy Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 205. Netherlands Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 206. Nordic Countries Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 207. China Seasonal Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 208. China Seasonal Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 209. China Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units) Table 210. China Seasonal Influenza Vaccines Sales by Type (2027-2032) & (W Units) Table 211. China Seasonal Influenza Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 212. China Seasonal Influenza Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 213. China Seasonal Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 214. China Seasonal Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 215. China Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units) Table 216. China Seasonal Influenza Vaccines Sales by Application (2027-2032) & (W Units) Table 217. China Seasonal Influenza Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 218. China Seasonal Influenza Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 219. Asia Seasonal Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 220. Asia Seasonal Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 221. Asia Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units) Table 222. Asia Seasonal Influenza Vaccines Sales by Type (2027-2032) & (W Units) Table 223. Asia Seasonal Influenza Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 224. Asia Seasonal Influenza Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 225. Asia Seasonal Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 226. Asia Seasonal Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 227. Asia Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units) Table 228. Asia Seasonal Influenza Vaccines Sales by Application (2027-2032) & (W Units) Table 229. Asia Seasonal Influenza Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 230. Asia Seasonal Influenza Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 231. Asia Seasonal Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 232. Asia Seasonal Influenza Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 233. Asia Seasonal Influenza Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 234. Asia Seasonal Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 235. Asia Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 236. Asia Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units) Table 237. Asia Seasonal Influenza Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 238. Asia Seasonal Influenza Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 239. Japan Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 240. South Korea Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 241. India Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 242. Australia Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 243. China Taiwan Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 244. Southeast Asia Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 245. SAMEA Seasonal Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 246. SAMEA Seasonal Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 247. SAMEA Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units) Table 248. SAMEA Seasonal Influenza Vaccines Sales by Type (2027-2032) & (W Units) Table 249. SAMEA Seasonal Influenza Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 250. SAMEA Seasonal Influenza Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 251. SAMEA Seasonal Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 252. SAMEA Seasonal Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 253. SAMEA Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units) Table 254. SAMEA Seasonal Influenza Vaccines Sales by Application (2027-2032) & (W Units) Table 255. SAMEA Seasonal Influenza Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 256. SAMEA Seasonal Influenza Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 257. SAMEA Seasonal Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 258. SAMEA Seasonal Influenza Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 259. SAMEA Seasonal Influenza Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 260. SAMEA Seasonal Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 261. SAMEA Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 262. SAMEA Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units) Table 263. SAMEA Seasonal Influenza Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 264. SAMEA Seasonal Influenza Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 265. Brazil Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 266. Argentina Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 267. Chile Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 268. Colombia Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 269. Peru Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 270. Saudi Arabia Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 271. Israel Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 272. UAE Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 273. Turkey Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 274. Iran Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 275. Egypt Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 276. Key Raw Materials Table 277. Raw Materials Key Suppliers Table 278. Seasonal Influenza Vaccines Distributors List Table 279. Seasonal Influenza Vaccines Customers List Table 280. Research Programs/Design for This Report Table 281. Authors List of This Report Table 282. Secondary Sources Table 283. Primary Sources List of Figures Figure 1. Seasonal Influenza Vaccines Image Figure 2. Global Seasonal Influenza Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Seasonal Influenza Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Type B Image Figure 5. Type A (H3N2) Image Figure 6. Type A (H1N1) Image Figure 7. Global Seasonal Influenza Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Seasonal Influenza Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 9. Adults Image Figure 10. Pediatrics Image Figure 11. Elderly Image Figure 12. Adolescence Image Figure 13. Global Seasonal Influenza Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million) Figure 15. Global Seasonal Influenza Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Seasonal Influenza Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2021-2032) Figure 18. Global Seasonal Influenza Vaccines Sales (2021-2032) & (W Units) Figure 19. Global Seasonal Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 20. Global Seasonal Influenza Vaccines Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Seasonal Influenza Vaccines Sales YoY (2021-2032) & (W Units) Figure 22. Europe Seasonal Influenza Vaccines Sales YoY (2021-2032) & (W Units) Figure 23. China Seasonal Influenza Vaccines Sales YoY (2021-2032) & (W Units) Figure 24. Asia (Excluding China) Seasonal Influenza Vaccines Sales YoY (2021-2032) & (W Units) Figure 25. South America, Middle East and Africa Seasonal Influenza Vaccines Sales YoY (2021-2032) & (W Units) Figure 26. Global Seasonal Influenza Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Seasonal Influenza Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Seasonal Influenza Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Seasonal Influenza Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2021-2032) Figure 32. Global Seasonal Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 33. Global Seasonal Influenza Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Seasonal Influenza Vaccines Sales Market Share by Type (2021-2032) Figure 35. Global Seasonal Influenza Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Seasonal Influenza Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2021-2032) Figure 38. Global Seasonal Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 39. Global Seasonal Influenza Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Seasonal Influenza Vaccines Sales Market Share by Application (2021-2032) Figure 41. North America Seasonal Influenza Vaccines Revenue Share by Type (2021-2032) Figure 42. North America Seasonal Influenza Vaccines Sales Share by Type (2021-2032) Figure 43. North America Seasonal Influenza Vaccines Revenue Share by Application (2021-2032) Figure 44. North America Seasonal Influenza Vaccines Sales Share by Application (2021-2032) Figure 45. North America Seasonal Influenza Vaccines Revenue Share by Country (2021-2032) Figure 46. North America Seasonal Influenza Vaccines Sales Share by Country (2021-2032) Figure 47. Europe Seasonal Influenza Vaccines Revenue Share by Type (2021-2032) Figure 48. Europe Seasonal Influenza Vaccines Sales Share by Type (2021-2032) Figure 49. Europe Seasonal Influenza Vaccines Revenue Share by Application (2021-2032) Figure 50. Europe Seasonal Influenza Vaccines Sales Share by Application (2021-2032) Figure 51. Europe Seasonal Influenza Vaccines Revenue Share by Country (2021-2032) Figure 52. Europe Seasonal Influenza Vaccines Sales Share by Country (2021-2032) Figure 53. China Seasonal Influenza Vaccines Revenue Share by Type (2021-2032) Figure 54. China Seasonal Influenza Vaccines Sales Share by Type (2021-2032) Figure 55. China Seasonal Influenza Vaccines Revenue Share by Application (2021-2032) Figure 56. China Seasonal Influenza Vaccines Sales Share by Application (2021-2032) Figure 57. Asia Seasonal Influenza Vaccines Revenue Share by Type (2021-2032) Figure 58. Asia Seasonal Influenza Vaccines Sales Share by Type (2021-2032) Figure 59. Asia Seasonal Influenza Vaccines Revenue Share by Application (2021-2032) Figure 60. Asia Seasonal Influenza Vaccines Sales Share by Application (2021-2032) Figure 61. Asia Seasonal Influenza Vaccines Revenue Share by Country (2021-2032) Figure 62. Asia Seasonal Influenza Vaccines Sales Share by Country (2021-2032) Figure 63. SAMEA Seasonal Influenza Vaccines Revenue Share by Type (2021-2032) Figure 64. SAMEA Seasonal Influenza Vaccines Sales Share by Type (2021-2032) Figure 65. SAMEA Seasonal Influenza Vaccines Revenue Share by Application (2021-2032) Figure 66. SAMEA Seasonal Influenza Vaccines Sales Share by Application (2021-2032) Figure 67. SAMEA Seasonal Influenza Vaccines Revenue Share by Country (2021-2032) Figure 68. SAMEA Seasonal Influenza Vaccines Sales Share by Country (2021-2032) Figure 69. Seasonal Influenza Vaccines Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Seasonal Influenza Vaccines Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Type B
  • Type A (H3N2)
  • Type A (H1N1)
Applications
  • Adults
  • Pediatrics
  • Elderly
  • Adolescence
Companies covered
  • Changsheng Bio-Technology
  • Sanofi
  • Novartis International AG
  • Merck & Co., Inc.
  • Pfizer Inc
  • GlaxoSmithKline plc
  • AstraZeneca
  • Viatris Inc.
  • Vaxess Technologies Inc
  • Sinovac Biotech Ltd
  • SINOVAC
  • OSIVAX
  • Jiangsu Simcere Vaxtec Bio-pharmaceutical
  • EMERGEX VACCINES
  • EMERGENT
  • Dalian Hissen Bio-pharm
  • CSL Limited
  • Ccbio SA
  • Aleph Biomedical
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Seasonal Influenza Vaccines Market by Type
  3. 1.2.1 Global Seasonal Influenza Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Type B
  5. 1.2.3 Type A (H3N2)
  6. 1.2.4 Type A (H1N1)
  7. 1.3 Seasonal Influenza Vaccines Market by Application
  8. 1.3.1 Global Seasonal Influenza Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Adults
  10. 1.3.3 Pediatrics
  11. 1.3.4 Elderly
  12. 1.3.5 Adolescence
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Seasonal Influenza Vaccines Market Dynamics
  1. 2.1 Seasonal Influenza Vaccines Industry Trends
  2. 2.2 Seasonal Influenza Vaccines Industry Drivers
  3. 2.3 Seasonal Influenza Vaccines Industry Opportunities and Challenges
  4. 2.4 Seasonal Influenza Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Seasonal Influenza Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Seasonal Influenza Vaccines Revenue by Region
  3. 3.2.1 Global Seasonal Influenza Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Seasonal Influenza Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Seasonal Influenza Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Seasonal Influenza Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Seasonal Influenza Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Seasonal Influenza Vaccines Sales by Region
  9. 3.4.1 Global Seasonal Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Seasonal Influenza Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Seasonal Influenza Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Seasonal Influenza Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Seasonal Influenza Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Seasonal Influenza Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Seasonal Influenza Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Seasonal Influenza Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Seasonal Influenza Vaccines Sales by Manufacturers
  6. 4.2.1 Global Seasonal Influenza Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Seasonal Influenza Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Seasonal Influenza Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Seasonal Influenza Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Seasonal Influenza Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Seasonal Influenza Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Seasonal Influenza Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Seasonal Influenza Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Seasonal Influenza Vaccines Tier 1, Tier 2, and Tier 3
5 Seasonal Influenza Vaccines Market by Type
  1. 5.1 Global Seasonal Influenza Vaccines Revenue by Type
  2. 5.1.1 Global Seasonal Influenza Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Seasonal Influenza Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Seasonal Influenza Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Seasonal Influenza Vaccines Sales by Type
  6. 5.2.1 Global Seasonal Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Seasonal Influenza Vaccines Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Seasonal Influenza Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Seasonal Influenza Vaccines Price by Type
6 Seasonal Influenza Vaccines Market by Application
  1. 6.1 Global Seasonal Influenza Vaccines Revenue by Application
  2. 6.1.1 Global Seasonal Influenza Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Seasonal Influenza Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Seasonal Influenza Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Seasonal Influenza Vaccines Sales by Application
  6. 6.2.1 Global Seasonal Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Seasonal Influenza Vaccines Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Seasonal Influenza Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Seasonal Influenza Vaccines Price by Application
7 Company Profiles
  1. 7.1 Changsheng Bio-Technology
  2. 7.1.1 Changsheng Bio-Technology Company Information
  3. 7.1.2 Changsheng Bio-Technology Business Overview
  4. 7.1.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio
  6. 7.1.5 Changsheng Bio-Technology Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Seasonal Influenza Vaccines Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Novartis International AG
  14. 7.3.1 Novartis International AG Company Information
  15. 7.3.2 Novartis International AG Business Overview
  16. 7.3.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis International AG Seasonal Influenza Vaccines Product Portfolio
  18. 7.3.5 Novartis International AG Recent Developments
  19. 7.4 Merck & Co., Inc.
  20. 7.4.1 Merck & Co., Inc. Company Information
  21. 7.4.2 Merck & Co., Inc. Business Overview
  22. 7.4.3 Merck & Co., Inc. Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio
  24. 7.4.5 Merck & Co., Inc. Recent Developments
  25. 7.5 Pfizer Inc
  26. 7.5.1 Pfizer Inc Company Information
  27. 7.5.2 Pfizer Inc Business Overview
  28. 7.5.3 Pfizer Inc Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Inc Seasonal Influenza Vaccines Product Portfolio
  30. 7.5.5 Pfizer Inc Recent Developments
  31. 7.6 GlaxoSmithKline plc
  32. 7.6.1 GlaxoSmithKline plc Company Information
  33. 7.6.2 GlaxoSmithKline plc Business Overview
  34. 7.6.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio
  36. 7.6.5 GlaxoSmithKline plc Recent Developments
  37. 7.7 AstraZeneca
  38. 7.7.1 AstraZeneca Company Information
  39. 7.7.2 AstraZeneca Business Overview
  40. 7.7.3 AstraZeneca Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 AstraZeneca Seasonal Influenza Vaccines Product Portfolio
  42. 7.7.5 AstraZeneca Recent Developments
  43. 7.8 Viatris Inc.
  44. 7.8.1 Viatris Inc. Company Information
  45. 7.8.2 Viatris Inc. Business Overview
  46. 7.8.3 Viatris Inc. Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Viatris Inc. Seasonal Influenza Vaccines Product Portfolio
  48. 7.8.5 Viatris Inc. Recent Developments
  49. 7.9 Vaxess Technologies Inc
  50. 7.9.1 Vaxess Technologies Inc Company Information
  51. 7.9.2 Vaxess Technologies Inc Business Overview
  52. 7.9.3 Vaxess Technologies Inc Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio
  54. 7.9.5 Vaxess Technologies Inc Recent Developments
  55. 7.10 Sinovac Biotech Ltd
  56. 7.10.1 Sinovac Biotech Ltd Company Information
  57. 7.10.2 Sinovac Biotech Ltd Business Overview
  58. 7.10.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio
  60. 7.10.5 Sinovac Biotech Ltd Recent Developments
  61. 7.11 SINOVAC
  62. 7.11.1 SINOVAC Company Information
  63. 7.11.2 SINOVAC Business Overview
  64. 7.11.3 SINOVAC Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 SINOVAC Seasonal Influenza Vaccines Product Portfolio
  66. 7.11.5 SINOVAC Recent Developments
  67. 7.12 OSIVAX
  68. 7.12.1 OSIVAX Company Information
  69. 7.12.2 OSIVAX Business Overview
  70. 7.12.3 OSIVAX Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 OSIVAX Seasonal Influenza Vaccines Product Portfolio
  72. 7.12.5 OSIVAX Recent Developments
  73. 7.13 Jiangsu Simcere Vaxtec Bio-pharmaceutical
  74. 7.13.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
  75. 7.13.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Business Overview
  76. 7.13.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio
  78. 7.13.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
  79. 7.14 EMERGEX VACCINES
  80. 7.14.1 EMERGEX VACCINES Company Information
  81. 7.14.2 EMERGEX VACCINES Business Overview
  82. 7.14.3 EMERGEX VACCINES Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio
  84. 7.14.5 EMERGEX VACCINES Recent Developments
  85. 7.15 EMERGENT
  86. 7.15.1 EMERGENT Company Information
  87. 7.15.2 EMERGENT Business Overview
  88. 7.15.3 EMERGENT Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 EMERGENT Seasonal Influenza Vaccines Product Portfolio
  90. 7.15.5 EMERGENT Recent Developments
  91. 7.16 Dalian Hissen Bio-pharm
  92. 7.16.1 Dalian Hissen Bio-pharm Company Information
  93. 7.16.2 Dalian Hissen Bio-pharm Business Overview
  94. 7.16.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio
  96. 7.16.5 Dalian Hissen Bio-pharm Recent Developments
  97. 7.17 CSL Limited
  98. 7.17.1 CSL Limited Company Information
  99. 7.17.2 CSL Limited Business Overview
  100. 7.17.3 CSL Limited Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 CSL Limited Seasonal Influenza Vaccines Product Portfolio
  102. 7.17.5 CSL Limited Recent Developments
  103. 7.18 Ccbio SA
  104. 7.18.1 Ccbio SA Company Information
  105. 7.18.2 Ccbio SA Business Overview
  106. 7.18.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Ccbio SA Seasonal Influenza Vaccines Product Portfolio
  108. 7.18.5 Ccbio SA Recent Developments
  109. 7.19 Aleph Biomedical
  110. 7.19.1 Aleph Biomedical Company Information
  111. 7.19.2 Aleph Biomedical Business Overview
  112. 7.19.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio
  114. 7.19.5 Aleph Biomedical Recent Developments
  115. 7.20 Abbott Laboratories
  116. 7.20.1 Abbott Laboratories Company Information
  117. 7.20.2 Abbott Laboratories Business Overview
  118. 7.20.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio
  120. 7.20.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Seasonal Influenza Vaccines Market Size by Type
  2. 8.1.1 North America Seasonal Influenza Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Seasonal Influenza Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Seasonal Influenza Vaccines Price by Type (2021-2032)
  5. 8.2 North America Seasonal Influenza Vaccines Market Size by Application
  6. 8.2.1 North America Seasonal Influenza Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Seasonal Influenza Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Seasonal Influenza Vaccines Price by Application (2021-2032)
  9. 8.3 North America Seasonal Influenza Vaccines Market Size by Country
  10. 8.3.1 North America Seasonal Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Seasonal Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Seasonal Influenza Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Seasonal Influenza Vaccines Market Size by Type
  2. 9.1.1 Europe Seasonal Influenza Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Seasonal Influenza Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Seasonal Influenza Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Seasonal Influenza Vaccines Market Size by Application
  6. 9.2.1 Europe Seasonal Influenza Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Seasonal Influenza Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Seasonal Influenza Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Seasonal Influenza Vaccines Market Size by Country
  10. 9.3.1 Europe Seasonal Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Seasonal Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Seasonal Influenza Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Seasonal Influenza Vaccines Market Size by Type
  2. 10.1.1 China Seasonal Influenza Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Seasonal Influenza Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Seasonal Influenza Vaccines Price by Type (2021-2032)
  5. 10.2 China Seasonal Influenza Vaccines Market Size by Application
  6. 10.2.1 China Seasonal Influenza Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Seasonal Influenza Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Seasonal Influenza Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Seasonal Influenza Vaccines Market Size by Type
  2. 11.1.1 Asia Seasonal Influenza Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Seasonal Influenza Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Seasonal Influenza Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Seasonal Influenza Vaccines Market Size by Application
  6. 11.2.1 Asia Seasonal Influenza Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Seasonal Influenza Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Seasonal Influenza Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Seasonal Influenza Vaccines Market Size by Country
  10. 11.3.1 Asia Seasonal Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Seasonal Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Seasonal Influenza Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Seasonal Influenza Vaccines Market Size by Type
  2. 12.1.1 SAMEA Seasonal Influenza Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Seasonal Influenza Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Seasonal Influenza Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Seasonal Influenza Vaccines Market Size by Application
  6. 12.2.1 SAMEA Seasonal Influenza Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Seasonal Influenza Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Seasonal Influenza Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Seasonal Influenza Vaccines Market Size by Country
  10. 12.3.1 SAMEA Seasonal Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Seasonal Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Seasonal Influenza Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Seasonal Influenza Vaccines Value Chain Analysis
  2. 13.1.1 Seasonal Influenza Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Seasonal Influenza Vaccines Production Mode & Process
  6. 13.2 Seasonal Influenza Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Seasonal Influenza Vaccines Distributors
  9. 13.2.3 Seasonal Influenza Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst